drugset / Trial / NCT01392014
Dihydroartemisinin-piperaquine and Primaquine for Uncomplicated Plasmodium Falciparum Cases
RandomizedParallel-groupOpen-labelPrevention
Summary
Artemisinin-based combination therapy (ACT) has been known to be controversial for stopping malaria transmission.The addition of primaquine (PQ) - the only drug commercially available that kills mature transmission stage - to such treatments might be necessary to eliminate this stage. A study is conducted to evaluate the efficacy of dihydroartemisinin-piperaquine (DHP) regimens with or without PQ on the sexual and asexual stages of P. falciparum in Sumatra, Indonesia.
Timeline
- Start
- 2008-12
- Primary completion
- 2010-03
- Completion
- 2010-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | ARTENIMOL | Small molecule | 40 mg | — |
| Comparator | ARTENIMOL | Small molecule | 60 mg | — |
| Comparator | ARTENIMOL | Small molecule | 80 mg | — |
| Comparator | ARTENIMOL | Small molecule | 120 mg | — |
| Comparator | Primaquine | Small molecule | 0.75 mg/kg | — |
| Comparator | piperaquine | Small molecule | 320 mg | — |
| Comparator | piperaquine | Small molecule | 480 mg | — |
| Comparator | piperaquine | Small molecule | 640 mg | — |
| Comparator | piperaquine | Small molecule | 960 mg | — |